Evidence map›Paper›PMID 33828518›Full record

ArticleFrontiers in neurology2021

Comparison of the Impact of Zika and Dengue Virus Infection, and Other Acute Illnesses of Unidentified Origin on Cognitive Functions in a Prospective Cohort in Chiapas Mexico.

Pablo F Belaunzarán-Zamudio, Ana M Ortega-Villa, Alberto J Mimenza-Alvarado, Paola Del Carmen Guerra-De-Blas, Sara G Aguilar-Navarro, Jesús Sepúlveda-Delgado, Sally Hunsberger, Raydel Valdés Salgado, José Ramos-Castañeda, Héctor Armando Rincón León and 8 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in neurology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed, 1 pooled it
1.8field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 1 synthesis or guideline pooled it, 12 citations in OpenAlex.

  1. Risk of cognitive decline among patients with dengue virus infection: a systematic review.The international journal of neuropsychopharmacology · 2024
    Pooled it
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Neurological and neuropsychological sequelae of Zika virus infection in children in León, Nicaragua.Revista panamericana de salud publica = Pan American journal of public health · 2022
    Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 10 institutions in 2 countries.

Pablo F Belaunzarán-ZamudioDepartamento de Infectología, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico.
Ana M Ortega-VillaBiostatistics Research Branch, Division of Clinical Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, United States.
Alberto J Mimenza-AlvaradoDepartment of Geriatric Medicine, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico.
Paola Del Carmen Guerra-De-BlasThe Mexican Emerging Infectious Diseases Clinical Research Network (LaRed), Mexico City, Mexico.
Sara G Aguilar-NavarroDepartment of Geriatric Medicine, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico.
Jesús Sepúlveda-DelgadoDirectorate of Research, Hospital Regional de Alta Especialidad Ciudad Salud, Tapachula & Medical Science Research, Hospital General de Zona 1, Instituto Mexicano del Seguro Social, Mexico City, Mexico.
Sally HunsbergerBiostatistics Research Branch, Division of Clinical Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, United States.
Raydel Valdés SalgadoWestat, Rockville, MD, United States.
José Ramos-CastañedaDepartamento de Infectología, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico.
Héctor Armando Rincón LeónInstituto Mexicano del Seguro Social, Delegación Estatal, Tapachula, Mexico.
Paul Rodríguez de La RosaDirectorate of Neurology, Hospital Regional de Alta Especialidad Ciudad Salud, Tapachula, Mexico.
José Gabriel Nájera CancinoDirectorate of Research, Hospital Regional de Alta Especialidad Ciudad Salud, Tapachula & Medical Science Research, Hospital General de Zona 1, Instituto Mexicano del Seguro Social, Mexico City, Mexico.
John BeigelNational Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, United States.
Sandra Caballero SosaClínica Hospital Dr. Roberto Nettel Flores, Instituto de Seguridad y Servicios Sociales de los Trabajadores del Estado, Tapachula, Mexico.
Emilia Ruiz HernándezDepartamento de Urgencias, Hospital General de Tapachula, Tapachula, Mexico.
John H PowersClinical Research Directorate, Frederick National Laboratory for Cancer Research, Frederick, MD, United States.
Guillermo M Ruiz-PalaciosDepartamento de Infectología, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico.
Clifford LaneNational Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, United States.
Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán · MXNational Institute of Allergy and Infectious Diseases · USHospital General De Zona · MXNational Institutes of Health · USFrederick National Laboratory for Cancer Research · USHospitales Regionales de Alta Especialidad · MXInstitute for Social Security and Services for State Workers · MXMexican Social Security Institute · MXUniversidad del Tacana · MXWestat (United States) · US

Funding

WORK ORDER 126643 B539 EXPAND IC SUITE75N91019D00024 · NIAID · LEIDOS BIOMEDICAL RESEARCH, INC. · PI BRISCOE, LYNN · 2019 to 2025
$3932.6M
CCR NIH HHS HHSN261200800001CNCI NIH HHS 75N91019D00024NCI NIH HHS HHSN261200800001ENIAID NIH HHS HHSN272200900001CNIAID NIH HHS HHSN272200900031C
6 · The paper itself

Abstract

Zika has been associated with a variety of severe neurologic manifestations including meningitis and encephalitis. We hypothesized that it may also cause mild to subclinical neurocognitive alterations during acute infection or over the long term. In this observational cohort study, we explored whether Zika cause subclinical or mild neurocognitive alterations, estimate its frequency and duration, and compare it to other acute illnesses in a cohort of people with suspected Zika infection, in the region of Tapachula in Chiapas, Mexico during 2016-2018. We enrolled patients who were at least 12 years old with suspected Zika virus infection and followed them up for 6 months. During each visit participants underwent a complete clinical exam, including a screening test for neurocognitive dysfunction (Montreal Cognitive Assessment score). We enrolled 406 patients [37 with Zika, 73 with dengue and 296 with other acute illnesses of unidentified origin (AIUO)]. We observed a mild and transient impact over cognitive functions in patients with Zika, dengue and with other AIUO. The probability of having an abnormal MoCA score (<26 points) was significantly higher in patients with Zika and AIUO than in those with dengue. Patients with Zika and AIUO had lower memory scores than patients with dengue (Zika vs. Dengue: -0.378, 95% CI-0.678 to -0.078;

Indexed as

cognitioncommunicable diseasesdengue virus infectionhumansmemorymental status and dementia testsmontreal cognitive assessmentzika virus infection

Identifiers

PMID33828518
PMCPMC8019918
OpenAlexW3138089027

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.